Clinical Features of False-Negative Early Gastric Cancers: A Retrospective Study of Endoscopic Submucosal Dissection Cases.
Journal
Gastroenterology research and practice
ISSN: 1687-6121
Titre abrégé: Gastroenterol Res Pract
Pays: Egypt
ID NLM: 101475557
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
10
2020
revised:
28
01
2021
accepted:
30
01
2021
entrez:
25
2
2021
pubmed:
26
2
2021
medline:
26
2
2021
Statut:
epublish
Résumé
We frequently encounter early gastric cancer (EGC) that could not be detected in the previous esophagogastroduodenoscopy even if the procedure was annually performed. However, little evidence exists regarding the characteristics of false-negative EGCs. Our aim was to reveal the clinical features of false-negative EGCs. We retrospectively reviewed cases of endoscopic submucosal dissection (ESD) for EGCs in Fukuchiyama City Hospital between January 2013 and May 2019. False-negative EGCs were defined as EGCs within 3 years of negative endoscopy. We evaluated the clinical characteristics of false-negative and initially detected EGCs and the difference in the detected and last missed endoscopy in false-negative EGCs. The miss rates of false-negative EGCs were compared between trainees (nonboard-certified endoscopists) and experienced endoscopists (board-certified endoscopists); thereafter, the characteristics of false-negative EGCs missed by trainees were investigated. Of 219 cases, 119 were classified as false-negative EGCs. False-negative EGCs were characterized as smaller lesions, which presented with normal color or gastritis-like appearance, and were diagnosed after ESD and The characteristics of false-negative EGCs were similar to those of
Sections du résumé
BACKGROUND
BACKGROUND
We frequently encounter early gastric cancer (EGC) that could not be detected in the previous esophagogastroduodenoscopy even if the procedure was annually performed. However, little evidence exists regarding the characteristics of false-negative EGCs. Our aim was to reveal the clinical features of false-negative EGCs.
METHODS
METHODS
We retrospectively reviewed cases of endoscopic submucosal dissection (ESD) for EGCs in Fukuchiyama City Hospital between January 2013 and May 2019. False-negative EGCs were defined as EGCs within 3 years of negative endoscopy. We evaluated the clinical characteristics of false-negative and initially detected EGCs and the difference in the detected and last missed endoscopy in false-negative EGCs. The miss rates of false-negative EGCs were compared between trainees (nonboard-certified endoscopists) and experienced endoscopists (board-certified endoscopists); thereafter, the characteristics of false-negative EGCs missed by trainees were investigated.
RESULTS
RESULTS
Of 219 cases, 119 were classified as false-negative EGCs. False-negative EGCs were characterized as smaller lesions, which presented with normal color or gastritis-like appearance, and were diagnosed after ESD and
CONCLUSION
CONCLUSIONS
The characteristics of false-negative EGCs were similar to those of
Identifiants
pubmed: 33628225
doi: 10.1155/2021/6635704
pmc: PMC7886521
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6635704Informations de copyright
Copyright © 2021 Kohei Oka et al.
Déclaration de conflit d'intérêts
Kohei Oka, Naoto Iwai, Takashi Okuda, Tasuku Hara, Yutaka Inada, Toshifumi Tsuji, Toshiyuki Komaki, Junichi Sakagami, Yuji Naito, Keizo Kagawa, and Yoshito Itoh have no conflicts of interest pertaining to this study.
Références
Gastrointest Endosc. 2008 Oct;68(4):635-41
pubmed: 18561923
Gastric Cancer. 2009;12(3):148-52
pubmed: 19890694
Gut. 1997 Sep;41(3):308-13
pubmed: 9378383
Dig Dis Sci. 2015 Apr;60(4):936-43
pubmed: 25316551
Gastroenterology. 2011 Dec;141(6):2017-2025.e3
pubmed: 21856268
Endoscopy. 1997 Jun;29(5):366-71
pubmed: 9270917
Endosc Int Open. 2017 Aug;5(8):E722-E726
pubmed: 28791319
Hepatogastroenterology. 2007 Mar;54(74):442-4
pubmed: 17523293
Gastric Cancer. 2016 Apr;19(2):524-530
pubmed: 25752268
Dig Endosc. 2017 Jul;29(5):569-575
pubmed: 28066945
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Fukushima J Med Sci. 2015;61(2):160-6
pubmed: 26632191
J Gastroenterol. 2006 Oct;41(10):929-42
pubmed: 17096062
Endosc Int Open. 2019 Feb;7(2):E164-E170
pubmed: 30705948
Digestion. 2012;86(2):161-70
pubmed: 22889937
Dig Dis Sci. 2010 Dec;55(12):3442-8
pubmed: 20393882
Clin Endosc. 2018 Jul;51(4):362-367
pubmed: 29695148
Endosc Int Open. 2014 Jun;2(2):E46-50
pubmed: 26135259
Helicobacter. 2011 Jun;16(3):210-6
pubmed: 21585606
Endosc Int Open. 2017 Aug;5(8):E727-E728
pubmed: 28791320
Gastrointest Endosc. 2003 Apr;57(4):475-82
pubmed: 12665756
Gastrointest Endosc. 2019 Jan;89(1):47-57
pubmed: 30189197
Gut. 2013 Oct;62(10):1425-32
pubmed: 22914298
N Engl J Med. 1991 Oct 17;325(16):1127-31
pubmed: 1891020
J Gastroenterol. 2019 May;54(5):396-406
pubmed: 30291440
N Engl J Med. 2010 May 13;362(19):1795-803
pubmed: 20463339
J Gastroenterol. 2013 Dec;48(12):1332-42
pubmed: 23420575
Eur J Gastroenterol Hepatol. 2005 Dec;17(12):1345-9
pubmed: 16292088
Gastrointest Endosc. 2014 Jan;79(1):55-63
pubmed: 23932092
Helicobacter. 1997 Jul;2 Suppl 1:S34-7
pubmed: 9432352
Clin Endosc. 2019 May;52(3):273-277
pubmed: 30103296